Stockholm 1 October 2019



Open Letter to Immunicum AB (publ) Shareholders



Proposal to the Nomination Committee for Immunicum AB (publ) and the 2020 Annual General Meeting


Compensation to the Board of Directors

Creopretium including related parties note that a majority of the board do not hold shares or hold a negligible number of shares in Immunicum AB (publ) in relation to compensation.


Table 1. Immunicum Board of Directorsʼ ownership and compensation

Appointed year

Number of shares

Value,

kSEK

Compensation 2018,  kSEK

Total compensation since appointment, kSEK

Value kSEK/total comp since appointment, (x)

Michael Oredsson, Chairman

2018

17,560

117

450

813

0.14

Charlotte Edenius

2016

4,000

27

150

513

0.05

Magnus Persson

2015

0

-

165

639

-

Steven Glazer

2016

0

-

175

594

-

Kerstin Valinder Strinnholm

2016

0

-

175

531

-

Source: Immunicum AB (publ)

Creopretium including related partiesʼ proposal:

The nomination committeeʼs proposal includes a recommendation regarding the compensation to the board of directors for 2020: each director of the board is recommended to purchase shares in an amount equal to at least 100% of the total compensation received in 2020 after tax has been deducted. 1

Creopretiumʼs rational behind the proposal:

  • Align board of directorsʼ interests with shareholders.
  • Signalling board of directorsʼ belief in Immunicum as an attractive investment.


Creopretiumʼs assessment is that this proposal to the annual general meeting 2020 is in the interest of all shareholders.


Yours sincerely,


Hans Derninger 

Managing Director




_____________________________

1 Under normal circumstances purchased shares shall not be divested before directorship has ended.





About Creopretium

Creopretium AB ("Creopretium") is a local operating partner to investors active in the Nordics. Creopretium offers advisory and co-investments where exceptional value can be unlocked through active ownership. Creopretium is a privated limited liability company under the laws of Sweden and registered with Swedish Companies Registration Office. Corporate registration number 556882–0111. The registered office of the board is in Stockholm, Sweden. For more information about Creopretium, please visit https://creopretium.se

Imprint   |   Terms and conditions  |   Privacy policy   |   Cookies policy   |   Feedback   |   Site map   |   Contact

© 2016–2020 Creopretium AB. All rights reserved.

This website uses cookies to ensure you get the best experience.

Learn more
Got it!